Eur J Pharmacol 149, 171-174, (1988). Sharkey, J., Glen, K. A., Wolfe, S., & Kuhar, M. J. View abstract in PubMed Post navigationPreviousPrevious post:The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog.NextNext post:Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems.Related PostsAnavex Life Sciences to Present at the 30th Annual ROTH ConferenceMarch 9, 2018Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018Anavex Life Sciences to Present at Cowen and Company 38th Annual Health Care ConferenceMarch 6, 2018Anavex Life Sciences Strengthens Management Team and Board of DirectorsMarch 5, 2018
Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018
